Wacker Biotech GmbH
Wacker Biotech GmbH, a prominent player in the biopharmaceutical industry, is headquartered in Germany (DE) and operates extensively across Europe and North America. Founded in 2000, the company has established itself as a leader in contract development and manufacturing, specialising in the production of complex biopharmaceuticals, including proteins and vaccines.
Wacker Biotech is renowned for its state-of-the-art facilities and innovative technologies, which enable the efficient production of high-quality biologics. The company’s commitment to excellence is reflected in its adherence to stringent regulatory standards and its successful collaborations with various global partners. With a strong market position, Wacker Biotech continues to achieve significant milestones, solidifying its reputation as a trusted provider in the biopharmaceutical sector.
+61 vs industry average
Wacker Biotech GmbH’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Wacker Biotech GmbH?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Wacker Biotech GmbH yet.
Wacker Biotech GmbH's reported carbon emissions
Wacker Biotech GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Wacker Chemie AG, which influences its climate commitments and initiatives.
Wacker Chemie AG, at the first cascade level, has established various climate initiatives, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Wacker Biotech GmbH have not been disclosed.
As a subsidiary, Wacker Biotech GmbH aligns with the broader sustainability goals set by Wacker Chemie AG, which may include commitments to reduce emissions across Scope 1, 2, and 3 categories. The absence of direct emissions data suggests that Wacker Biotech GmbH is still in the process of developing its specific climate strategy and targets.
Overall, while Wacker Biotech GmbH inherits a commitment to sustainability from its parent company, detailed emissions metrics and reduction targets remain unspecified at this time.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Wacker Biotech GmbH’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Wacker Biotech GmbH yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Wacker Chemie AG
Carbon Disclosure Project
Inherited from Wacker Chemie AG
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Wacker Chemie AG
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project